Central Catheters
- Hemodialysis Catheters
- Implantable Ports
- Peripherally Inserted Central Catheters (PICC)
- Central Venous Catheters (CVC)
2. Peripheral Catheters
- Peripheral Intravenous Catheters (PIVC)
- Midline Catheters
3. Accessories
Vascular access devices market size was valued at USD 3.88 billion in 2022 and is projected to reach USD 6.17 billion by 2029, growing at a CAGR of 6.8% from 2023 to 2029. Vascular access is a method of introducing or removing devices or chemicals from the bloodstream. Vascular access devices (VADs) are medical devices that are inserted into veins via peripheral or central vessels for diagnostic or therapeutic reasons, such as blood sampling, central venous pressure readings, administration of medication, fluids, total parenteral nutrition (TPN), and blood transfusions. One of the primary forces fueling the growth of the global market is technological improvements in the field of vascular access devices. The Global Vascular Access Devices Market research offers a comprehensive analysis of the industry. The research includes a detailed analysis of key segments, trends, drivers, constraints, the competitive landscape, and other important market variables. Central venous pressure readings, fluids, blood sampling, total parental nourishment, blood transfusion, and medicine administration are examples of diagnostic instruments. Through peripheral vessels, these devices are introduced into veins. Because of advances in diagnostics, treatments, and therapies, the demand for vascular access devices is growing. The vascular access devices offer the capacity to mix a solution containing nutritional components without causing complications.
Study Period
Base Year
CAGR
Largest Market
Fastest Growing Market
Increase in the prevalence of the chronic disorders such as obesity, cardiac disorders, and diabetes are the key factors attributing the growth of the vascular access devices. Growing incidence of the kidney disorders is adding fuel for the growth of the market. The changing lifestyles resulting in various health related issues are driving the growth off the market. The technological advancements in the field of vascular access is anticipating the growth of the market. The growing government initiatives is further adding scope for the growth of the vascular access devices. However, the high cost associated with treatment is hampering the growth of the vascular access devices market.
Central Catheters
2. Peripheral Catheters
3. Accessories
The vascular access devices market size was valued at USD 3.88 billion in 2022.
The report covers the five regions and 15+ countries market data: North America (United States, Canada), Europe (Germany, France, Italy, Spain, and United Kingdom (UK), Asia Pacific (China, India, Japan, Australia & New Zealand), Latin America (Brazil, Mexico, Argentina) and Middle East and Africa (Saudi Arabia, United Arab Emirates, South Africa).
In our report, we provide 12-15 market players’ information into the report. However, based on the client’s request we will provide additional country and regional market players information as well.
The vascular access devices market key players are: Becton, Dickinson & Company (U.S.), Medtronic (U.S.), Revolutions Medical Corporation (U.S.), Retractable Technologies, Inc. (U.S.), Royal Imtech N.V. (Smiths Medical) (Netherlands, Terumo Corporation (Japan), Unilife Corporation (U.S.), Sol-Millennium Medical Group (China), Ultimed, Inc. (U.S.), Axel Bio Corporation (U.S.)
1.Executive Summary |
2.Global Vascular Access Devices Market Introduction |
2.1.Global Vascular Access Devices Market - Taxonomy |
2.2.Global Vascular Access Devices Market - Definitions |
2.2.1.Product |
2.2.2.Application |
2.2.3.Route of Insertion |
2.2.4.End User |
2.2.5.Region |
3.Global Vascular Access Devices Market Dynamics |
3.1. Drivers |
3.2. Restraints |
3.3. Opportunities/Unmet Needs of the Market |
3.4. Trends |
3.5. Product Landscape |
3.6. New Product Launches |
3.7. Impact of COVID 19 on Market |
4.Global Vascular Access Devices Market Analysis, 2018-2022 and Forecast 2023-2029 |
4.1. Market Analysis, 2018-2022 and Forecast, 2023-2029, (Sales Value USD Million) |
4.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) |
4.3. Market Opportunity Analysis |
5.Global Vascular Access Devices Market By Product, 2018-2022 and Forecast 2023-2029 (Sales Value USD Million) |
5.1. Central Catheters |
5.1.1. Market Analysis, 2018-2022 and Forecast, 2023-2029, (Sales Value USD Million) |
5.1.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
5.1.3. Market Opportunity Analysis |
5.2. Peripheral Catheters |
5.2.1. Market Analysis, 2018-2022 and Forecast, 2023-2029, (Sales Value USD Million) |
5.2.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
5.2.3. Market Opportunity Analysis |
5.3. Accessorie |
5.3.1. Market Analysis, 2018-2022 and Forecast, 2023-2029, (Sales Value USD Million) |
5.3.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
5.3.3. Market Opportunity Analysis |
6.Global Vascular Access Devices Market By Application, 2018-2022 and Forecast 2023-2029 (Sales Value USD Million) |
6.1. Transfusion of Blood Products |
6.1.1. Market Analysis, 2018-2022 and Forecast, 2023-2029, (Sales Value USD Million) |
6.1.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
6.1.3. Market Opportunity Analysis |
6.2. Diagnostic Testing |
6.2.1. Market Analysis, 2018-2022 and Forecast, 2023-2029, (Sales Value USD Million) |
6.2.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
6.2.3. Market Opportunity Analysis |
6.3. Medication Administration |
6.3.1. Market Analysis, 2018-2022 and Forecast, 2023-2029, (Sales Value USD Million) |
6.3.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
6.3.3. Market Opportunity Analysis |
7.Global Vascular Access Devices Market By Route of Insertion, 2018-2022 and Forecast 2023-2029 (Sales Value USD Million) |
7.1. Subcutaneous |
7.1.1. Market Analysis, 2018-2022 and Forecast, 2023-2029, (Sales Value USD Million) |
7.1.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
7.1.3. Market Opportunity Analysis |
7.2. Intravenous |
7.2.1. Market Analysis, 2018-2022 and Forecast, 2023-2029, (Sales Value USD Million) |
7.2.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
7.2.3. Market Opportunity Analysis |
8.Global Vascular Access Devices Market By End User, 2018-2022 and Forecast 2023-2029 (Sales Value USD Million) |
8.1. Hospitals |
8.1.1. Market Analysis, 2018-2022 and Forecast, 2023-2029, (Sales Value USD Million) |
8.1.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
8.1.3. Market Opportunity Analysis |
8.2. Ambulatory Surgery Centers |
8.2.1. Market Analysis, 2018-2022 and Forecast, 2023-2029, (Sales Value USD Million) |
8.2.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
8.2.3. Market Opportunity Analysis |
8.3. Others |
8.3.1. Market Analysis, 2018-2022 and Forecast, 2023-2029, (Sales Value USD Million) |
8.3.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
8.3.3. Market Opportunity Analysis |
9.Global Vascular Access Devices Market By Region, 2018-2022 and Forecast 2023-2029 (Sales Value USD Million) |
9.1. North America |
9.1.1. Market Analysis, 2018-2022 and Forecast, 2023-2029, (Sales Value USD Million) |
9.1.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
9.1.3. Market Opportunity Analysis |
9.2. Europe |
9.2.1. Market Analysis, 2018-2022 and Forecast, 2023-2029, (Sales Value USD Million) |
9.2.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
9.2.3. Market Opportunity Analysis |
9.3. Asia Pacific (APAC) |
9.3.1. Market Analysis, 2018-2022 and Forecast, 2023-2029, (Sales Value USD Million) |
9.3.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
9.3.3. Market Opportunity Analysis |
9.4. Middle East and Africa (MEA) |
9.4.1. Market Analysis, 2018-2022 and Forecast, 2023-2029, (Sales Value USD Million) |
9.4.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
9.4.3. Market Opportunity Analysis |
9.5. Latin America |
9.5.1. Market Analysis, 2018-2022 and Forecast, 2023-2029, (Sales Value USD Million) |
9.5.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
9.5.3. Market Opportunity Analysis |
10.North America Vascular Access Devices Market ,2018-2022 and Forecast 2023-2029 (Sales Value USD Million) |
10.1. Product Analysis 2018-2022 and Forecast 2023-2029 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
10.1.1.Central Catheters |
10.1.2.Peripheral Catheters |
10.1.3.Accessorie |
10.2. Application Analysis 2018-2022 and Forecast 2023-2029 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
10.2.1.Transfusion of Blood Products |
10.2.2.Diagnostic Testing |
10.2.3.Medication Administration |
10.3. Route of Insertion Analysis 2018-2022 and Forecast 2023-2029 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
10.3.1.Subcutaneous |
10.3.2.Intravenous |
10.4. End User Analysis 2018-2022 and Forecast 2023-2029 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
10.4.1.Hospitals |
10.4.2.Ambulatory Surgery Centers |
10.4.3.Others |
10.5. Country Analysis 2018-2022 and Forecast 2023-2029 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
10.5.1.United States of America (USA) |
10.5.2.Canada |
11.Europe Vascular Access Devices Market ,2018-2022 and Forecast 2023-2029 (Sales Value USD Million) |
11.1. Product Analysis and Forecast by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
11.1.1.Central Catheters |
11.1.2.Peripheral Catheters |
11.1.3.Accessorie |
11.2. Application Analysis 2018-2022 and Forecast 2023-2029 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
11.2.1.Transfusion of Blood Products |
11.2.2.Diagnostic Testing |
11.2.3.Medication Administration |
11.3. Route of Insertion Analysis 2018-2022 and Forecast 2023-2029 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
11.3.1.Subcutaneous |
11.3.2.Intravenous |
11.4. End User Analysis 2018-2022 and Forecast 2023-2029 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
11.4.1.Hospitals |
11.4.2.Ambulatory Surgery Centers |
11.4.3.Others |
11.5. Country Analysis 2018-2022 and Forecast 2023-2029 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
11.5.1.Germany |
11.5.2.France |
11.5.3.Italy |
11.5.4.United Kingdom (UK) |
11.5.5.Spain |
11.5.6.Rest of EU |
12.Asia Pacific (APAC) Vascular Access Devices Market ,2018-2022 and Forecast 2023-2029 (Sales Value USD Million) |
12.1. Product Analysis and Forecast by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
12.1.1.Central Catheters |
12.1.2.Peripheral Catheters |
12.1.3.Accessorie |
12.2. Application Analysis 2018-2022 and Forecast 2023-2029 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
12.2.1.Transfusion of Blood Products |
12.2.2.Diagnostic Testing |
12.2.3.Medication Administration |
12.3. Route of Insertion Analysis 2018-2022 and Forecast 2023-2029 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
12.3.1.Subcutaneous |
12.3.2.Intravenous |
12.4. End User Analysis 2018-2022 and Forecast 2023-2029 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
12.4.1.Hospitals |
12.4.2.Ambulatory Surgery Centers |
12.4.3.Others |
12.5. Country Analysis 2018-2022 and Forecast 2023-2029 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
12.5.1.China |
12.5.2.India |
12.5.3.Australia and New Zealand (ANZ) |
12.5.4.Japan |
12.5.5.Rest of APAC |
13.Middle East and Africa (MEA) Vascular Access Devices Market ,2018-2022 and Forecast 2023-2029 (Sales Value USD Million) |
13.1. Product Analysis and Forecast by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
13.1.1.Central Catheters |
13.1.2.Peripheral Catheters |
13.1.3.Accessorie |
13.2. Application Analysis 2018-2022 and Forecast 2023-2029 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
13.2.1.Transfusion of Blood Products |
13.2.2.Diagnostic Testing |
13.2.3.Medication Administration |
13.3. Route of Insertion Analysis 2018-2022 and Forecast 2023-2029 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
13.3.1.Subcutaneous |
13.3.2.Intravenous |
13.4. End User Analysis 2018-2022 and Forecast 2023-2029 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
13.4.1.Hospitals |
13.4.2.Ambulatory Surgery Centers |
13.4.3.Others |
13.5. Country Analysis 2018-2022 and Forecast 2023-2029 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
13.5.1.GCC Countries |
13.5.2.South Africa |
13.5.3.Rest of MEA |
14.Latin America Vascular Access Devices Market ,2018-2022 and Forecast 2023-2029 (Sales Value USD Million) |
14.1. Product Analysis and Forecast by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
14.1.1.Central Catheters |
14.1.2.Peripheral Catheters |
14.1.3.Accessorie |
14.2. Application Analysis 2018-2022 and Forecast 2023-2029 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
14.2.1.Transfusion of Blood Products |
14.2.2.Diagnostic Testing |
14.2.3.Medication Administration |
14.3. Route of Insertion Analysis 2018-2022 and Forecast 2023-2029 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
14.3.1.Subcutaneous |
14.3.2.Intravenous |
14.4. End User Analysis 2018-2022 and Forecast 2023-2029 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
14.4.1.Hospitals |
14.4.2.Ambulatory Surgery Centers |
14.4.3.Others |
14.5. Country Analysis 2018-2022 and Forecast 2023-2029 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
14.5.1.Brazil |
14.5.2.Mexico |
14.5.3.Rest of LA |
15. Competition Landscape |
15.1. Market Player Profiles (Introduction, Brand/Product Sales, Financial Analysis, Product Offerings, Key Developments, Collaborations, M & A, Strategies, and SWOT Analysis) |
15.2.1.Becton, Dickinson & Company (U.S.) |
15.2.2.Medtronic (U.S.) |
15.2.3.Revolutions Medical Corporation (U.S.) |
15.2.4.Retractable Technologies, Inc. (U.S.) |
15.2.5.Royal Imtech N.V. (Smiths Medical) |
15.2.6 Terumo Corporation (Japan) |
15.2.7.Unilife Corporation (U.S.) |
15.2.8 Sol-Millennium Medical Group (China) |
15.2.9.Ultimed, Inc. (U.S.) |
15.2.10.Axel Bio Corporation (U.S.) |
16. Research Methodology |
17. Appendix and Abbreviations |